125 related articles for article (PubMed ID: 29086372)
1. Deep Sequencing Reveals a MicroRNA Expression Signature in Triple-Negative Breast Cancer.
Chang YY; Lai LC; Tsai MH; Chuang EY
Methods Mol Biol; 2018; 1699():99-111. PubMed ID: 29086372
[TBL] [Abstract][Full Text] [Related]
2. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
3. Deep sequencing reveals complex mechanisms of microRNA deregulation in colorectal cancer.
Liang G; Li J; Sun B; Li S; Lü L; Wang Y; Chen B; Xiao Z
Int J Oncol; 2014 Aug; 45(2):603-10. PubMed ID: 24889194
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.
Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H
Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775
[TBL] [Abstract][Full Text] [Related]
6. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
[TBL] [Abstract][Full Text] [Related]
7. Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next‑generation sequencing.
Wu H; Wang Q; Zhong H; Li L; Zhang Q; Huang Q; Yu Z
Oncol Rep; 2020 Jan; 43(1):240-250. PubMed ID: 31746410
[TBL] [Abstract][Full Text] [Related]
8. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
Buschmann D; González R; Kirchner B; Mazzone C; Pfaffl MW; Schelling G; Steinlein O; Reithmair M
Int J Oncol; 2018 Jun; 52(6):1765-1776. PubMed ID: 29620157
[TBL] [Abstract][Full Text] [Related]
10. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing for MicroRNA Expression Profile.
Hu Y; Lan W; Miller D
Methods Mol Biol; 2017; 1617():169-177. PubMed ID: 28540684
[TBL] [Abstract][Full Text] [Related]
12. Exploring microRNA Regulation of Cancer with Context-Aware Deep Cancer Classifier.
Pyman B; Sedghi A; Azizi S; Tyryshkin K; Renwick N; Mousavi P
Pac Symp Biocomput; 2019; 24():160-171. PubMed ID: 30864319
[TBL] [Abstract][Full Text] [Related]
13. Identification and expression profiling of Vigna mungo microRNAs from leaf small RNA transcriptome by deep sequencing.
Paul S; Kundu A; Pal A
J Integr Plant Biol; 2014 Jan; 56(1):15-23. PubMed ID: 24138283
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome-Wide Comparative Analysis of microRNA Profiles in the Telogen Skins of Liaoning Cashmere Goats (Capra hircus) and Fine-Wool Sheep (Ovis aries) by Solexa Deep Sequencing.
Li J; Qu H; Jiang H; Zhao Z; Zhang Q
DNA Cell Biol; 2016 Nov; 35(11):696-705. PubMed ID: 27754706
[TBL] [Abstract][Full Text] [Related]
15. Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer.
Guo X; Cai Q; Bao P; Wu J; Wen W; Ye F; Zheng W; Zheng Y; Shu XO
Cancer; 2016 Aug; 122(16):2544-51. PubMed ID: 27183356
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control.
de Rinaldis E; Gazinska P; Mera A; Modrusan Z; Fedorowicz GM; Burford B; Gillett C; Marra P; Grigoriadis A; Dornan D; Holmberg L; Pinder S; Tutt A
BMC Genomics; 2013 Sep; 14():643. PubMed ID: 24059244
[TBL] [Abstract][Full Text] [Related]
17. A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.
García-Vazquez R; Ruiz-García E; Meneses García A; Astudillo-de la Vega H; Lara-Medina F; Alvarado-Miranda A; Maldonado-Martínez H; González-Barrios JA; Campos-Parra AD; Rodríguez Cuevas S; Marchat LA; López-Camarillo C
Tumour Biol; 2017 Jun; 39(6):1010428317702899. PubMed ID: 28621239
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
[TBL] [Abstract][Full Text] [Related]
19. Analysis of miRNA expression profiles in breast cancer using biclustering.
Fiannaca A; La Rosa M; La Paglia L; Rizzo R; Urso A
BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S7. PubMed ID: 25734576
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis of MicroRNA expression in enamel-producing cells.
Nirvani M; Khuu C; Tulek A; Utheim TP; Sand LP; Snead ML; Sehic A
Gene; 2019 Mar; 688():193-203. PubMed ID: 30529249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]